Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 29

Results For "ANDA"

2932 News Found

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India
interviews | April 30, 2026

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems


KIMS enters into MoU for strategic clinical collaboration
Healthcare | April 30, 2026

KIMS enters into MoU for strategic clinical collaboration

The association is intended to strengthen healthcare delivery standards, particularly in Oncology services, and enhance patient care outcomes


GSK wins regulatory boost for once-monthly liver drug efimosfermin in MASH push
News | April 30, 2026

GSK wins regulatory boost for once-monthly liver drug efimosfermin in MASH push

The twin designations are designed to speed up the development and review of promising medicines targeting serious conditions with high unmet need


Sahajanand Medical Technologies secures ISO 50001:2018 certification for Surat, Hyderabad facilities
Medical Device | April 30, 2026

Sahajanand Medical Technologies secures ISO 50001:2018 certification for Surat, Hyderabad facilities

Certification reinforces energy efficiency, sustainability goals, and green manufacturing across SMT’s Surat and Hyderabad facilities


Solara announces closure of US FDA inspection at Puducherry facility
Drug Approval | April 30, 2026

Solara announces closure of US FDA inspection at Puducherry facility

The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets


Wanbury's Patalganga site clears Korea FDA inspection with zero observations
Drug Approval | April 30, 2026

Wanbury's Patalganga site clears Korea FDA inspection with zero observations

Patalganga plant received zero observation from USFDA earlier


Pfizer drug delivers breakthrough in late-stage blood cancer trial
Clinical Trials | April 30, 2026

Pfizer drug delivers breakthrough in late-stage blood cancer trial

Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis


Zealand Pharma and Roche charge into Phase 3 with obesity drug bet
Clinical Trials | April 30, 2026

Zealand Pharma and Roche charge into Phase 3 with obesity drug bet

The Danish biotech company confirmed the global study will begin in the second half of 2026


Gen Z split on AI as global study reveals rising tech optimism
Technology | April 30, 2026

Gen Z split on AI as global study reveals rising tech optimism

Health innovations are viewed more positively than food and agricultural technologies


India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework
Policy | April 30, 2026

India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework

Landmark agreement opens market access, mobility pathways, and institutional collaboration for Ayurveda, Yoga, and holistic healthcare services